By Ludwig Burger and Maggie Fick FRANKFURT (Reuters) - Supplies of Novo Nordisk's popular weight-loss drug Wegovy are limited in Germany less than a m.
Supplies of Novo Nordisk's popular weight-loss drug Wegovy are limited in Germany less than a month after its launch in Europe's largest drug market, major drug distributors and doctors told Reuters. The volumes of the weekly injection that the Danish drugmaker has delivered to the country so far have fallen short of strong demand, the wholesalers said. "Demand is by far exceeding the available volumes," a spokesperson for Noweda, which has almost a quarter of the German drug wholesale trade, told Reuters, adding the problem was nationwide.